Your browser doesn't support javascript.
loading
Pilot Intervention to Improve Medication Adherence Among Patients With Systemic Lupus Erythematosus Using Pharmacy Refill Data.
Sun, Kai; Eudy, Amanda M; Rogers, Jennifer L; Criscione-Schreiber, Lisa G; Sadun, Rebecca E; Doss, Jayanth; Maheswaranathan, Mithu; Barr, Ann Cameron; Eder, Lena; Corneli, Amy L; Bosworth, Hayden B; Clowse, Megan E B.
Afiliación
  • Sun K; Duke University School of Medicine, Durham, North Carolina.
  • Eudy AM; Duke University School of Medicine, Durham, North Carolina.
  • Rogers JL; Duke University School of Medicine, Durham, North Carolina.
  • Criscione-Schreiber LG; Duke University School of Medicine, Durham, North Carolina.
  • Sadun RE; Duke University School of Medicine, Durham, North Carolina.
  • Doss J; Duke University School of Medicine, Durham, North Carolina.
  • Maheswaranathan M; Duke University School of Medicine, Durham, North Carolina.
  • Barr AC; Duke University School of Medicine, Durham, North Carolina.
  • Eder L; Duke University School of Medicine, Durham, North Carolina.
  • Corneli AL; Duke University School of Medicine, Durham, North Carolina.
  • Bosworth HB; Duke University School of Medicine, Durham, North Carolina.
  • Clowse MEB; Duke University School of Medicine, Durham, North Carolina.
Arthritis Care Res (Hoboken) ; 75(3): 550-558, 2023 03.
Article en En | MEDLINE | ID: mdl-34739191
OBJECTIVE: Despite high rates of medication nonadherence among patients with systemic lupus erythematosus (SLE), effective interventions to improve adherence in SLE are limited. We aimed to assess the feasibility of a pilot intervention and explore its effect on adherence. METHODS: The intervention used pharmacy refill data to monitor nonadherence and prompt discussions surrounding SLE medications during clinic encounters. Over 12 weeks, the intervention was delivered through routine clinic visits by providers to patients with SLE who take SLE-specific medications. We measured acceptability, appropriateness, and feasibility using provider surveys. We also measured acceptability by patient surveys and feasibility by medical record documentation. We explored change in adherence by comparing percent of patients with medication possession ratio (MPR) ≥80% 3 months before and after the intervention visit using the McNemar's test. RESULTS: Six rheumatologists participated; 130 patients were included in the analysis (median age 43, 95% female, and 59% racial and ethnic minorities). Implementation of the intervention was documented in 89% of clinic notes. Provider surveys showed high scores for feasibility (4.7/5), acceptability (4.4/5), and appropriateness (4.6/5). Among patient surveys, the most common reactions to the intervention visit were feeling determined (32%), empowered (32%), and proud (19%). Proportion of patients with MPR ≥80% increased from 48% to 58% (P = 0.03) after the intervention visit. CONCLUSION: Our intervention showed feasibility, acceptability, and appropriateness and led to a statistically significant improvement in adherence. Future work should refine the intervention, assess its efficacy in a controlled setting, and adapt its use among other clinic settings.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacia / Lupus Eritematoso Sistémico Límite: Adult / Female / Humans / Male Idioma: En Revista: Arthritis Care Res (Hoboken) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacia / Lupus Eritematoso Sistémico Límite: Adult / Female / Humans / Male Idioma: En Revista: Arthritis Care Res (Hoboken) Asunto de la revista: REUMATOLOGIA Año: 2023 Tipo del documento: Article Pais de publicación: Estados Unidos